Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
Leukemia|June 7, 2013
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyA Tefferi, E Rumi, G Finazzi, et al.
Leukemia|August 22, 2015
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working groupN M Kröger, J H Deeg, E Olavarria, et al.
Annals of Hematology|August 21, 2013
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)M Mian, D Capello, M B Ventre, et al.
Leukemia|July 27, 2017
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patientsS Ruberti, E Bianchi, P Guglielmelli, et al.
Diabetes, Obesity & Metabolism|March 10, 2009
Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trialL Lundby Christensen, T Almdal, T Boesgaard, et al.
Leukemia|June 1, 2017
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosisF Passamonti, T Giorgino, B Mora, et al.
Bone Marrow Transplantation|January 21, 2014
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosisM Magni, M Di Nicola, C Patti, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Leukemia|March 22, 2017
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring SystemM G Della Porta, C H Jackson, E P Alessandrino, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Pageof 36